← Leaderboards
Kathleen Miho Sakamoto
University Of California Los Angeles
$11,054,872
Attributed
$13,481,383
Total exposure
16
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$15,895,923 · 17
By mechanism
R01$9,246,306 · 5
T32$2,949,356 · 2
U2C$2,414,540 · 1
R21$428,686 · 1
R25$427,182 · 1
R56$263,240 · 2
Top collaborators
- Shuo Lin9 shared
- Bonnie L Halpern-Felsher4 shared
- Maria Barna3 shared
- Elaine Ku3 shared
- Marshall Stoller3 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Alcino J. Silva$34,334,032
- Fernando Gomez-Pinilla$14,573,294
- Hua Linda Cai$18,515,897
- Stephan G Anagnostaras$1,706,791
- David A Hovda$5,787,123
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsHematologyPhenotypeHematopoieticIn VivoCellsMolecularTrainingHematopoiesisIn VitroPathogenesisStem CellsLeadChildhoodPharmaceutical PreparationsAffectHematopoietic Stem CellsFutureResearch PersonnelInsightNon-MalignantProgramsMouse ModelFunctional Disorder
Grant awards (59)
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$832,600
U2C · FY2025 · DK
Investigating and targeting the translational landscape of DBA$672,665
R01 · FY2025 · DK
Increasing Diversity in Hematology: Training for Underrepresented Students$105,567
R25 · FY2025 · DK · contact PI
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$749,339
U2C · FY2024 · DK
Investigating and targeting the translational landscape of DBA$678,778
R01 · FY2024 · DK
Increasing Diversity in Hematology: Training for Underrepresented Students$106,402
R25 · FY2024 · DK · contact PI
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology$832,601
U2C · FY2023 · DK
Investigating and targeting the translational landscape of DBA$150,000
R56 · FY2023 · DK
Increasing Diversity in Hematology: Training for Underrepresented Students$107,213
R25 · FY2023 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$234,480
T32 · FY2022 · DK · contact PI
Increasing Diversity in Hematology: Training for Underrepresented Students$108,000
R25 · FY2022 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$226,995
T32 · FY2021 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$117,399
T32 · FY2020 · DK · contact PI
Signaling Pathways in MDS$351,720
R01 · FY2019 · DK · contact PI
Signaling Pathways in MDS$351,188
R01 · FY2018 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$313,733
T32 · FY2018 · DK · contact PI
Signaling Pathways in MDS$350,691
R01 · FY2017 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$297,451
T32 · FY2017 · DK · contact PI
Signaling Pathways in MDS$363,278
R01 · FY2016 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$258,806
T32 · FY2016 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$286,716
T32 · FY2015 · DK · contact PI
Signaling Pathways in MDS$113,240
R56 · FY2015 · DK · contact PI
Training in Pediatric Nonmalignant Hematology and Stem Cell Biology$157,232
T32 · FY2014 · DK · contact PI
Professional Development and Late Career Transitions in Pediatric Hematology/Onco$2,500
R13 · FY2014 · CA · contact PI
Molecular Pathogenesis of Diamond Blackfan Anemia$441,741
R01 · FY2013 · HL · contact PI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis$408,074
R01 · FY2013 · HL · contact PI
Career Development and Increasing Diversity in Pediatric Hematology/Oncology$5,000
R13 · FY2013 · CA · contact PI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis$464,302
R01 · FY2012 · HL · contact PI
Molecular Pathogenesis of Diamond Blackfan Anemia$463,934
R01 · FY2012 · HL · contact PI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis$445,409
R01 · FY2011 · HL · contact PI
Molecular Pathogenesis of Diamond Blackfan Anemia$385,000
R01 · FY2011 · HL · contact PI
Molecular Pathogenesis of Diamond Blackfan Anemia$70,326
R01 · FY2011 · HL · contact PI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis$28,167
R01 · FY2011 · HL · contact PI
Career Development and Increasing Diversity in Pediatric Hematology/Oncology$5,001
R13 · FY2011 · CA · contact PI
Molecular Pathogenesis of Diamond Blackfan Anemia$385,000
R01 · FY2010 · HL · contact PI
The Role of CREB in Normal Myelopoiesis and Leukemogenesis$379,965
R01 · FY2010 · HL · contact PI
Training in Developmental Hematology$266,752
T32 · FY2010 · HL · contact PI
Molecular and Cellular Characterization of Myeloproliferative Disease$46,200
R01 · FY2010 · HL · contact PI
Career Development and Increasing Diversity in Pediatric Hematology/Oncology$10,000
R13 · FY2010 · HL · contact PI
Training in Developmental Hematology$264,814
T32 · FY2009 · HL · contact PI
Molecular and Cellular Characterization of Myeloproliferative Disease$46,200
R01 · FY2009 · HL · contact PI
Molecular and Cellular Characterization of Myeloproliferative Disease$391,483
R01 · FY2008 · HL · contact PI
Training in Developmental Hematology$262,489
T32 · FY2008 · HL · contact PI
Molecular and Cellular Characterization of Myeloprolife*$35,522
R01 · FY2008 · HL · contact PI
The Role Of CREB In Leukemogenesis$409,529
R01 · FY2007 · HL · contact PI
Molecular and Cellular Characterization of Myeloproliferative Disease$329,612
R01 · FY2007 · HL · contact PI
Training in Developmental Hematology$262,489
T32 · FY2007 · HL · contact PI
The Role Of CREB In Leukemogenesis$398,712
R01 · FY2006 · HL · contact PI
Molecular and Cellular Characterization of Myeloprolife*$339,457
R01 · FY2006 · HL · contact PI
Molecular and Cellular Characterization of MPD$347,625
R01 · FY2005 · HL
The Role Of CREB In Leukemogenesis$305,543
R01 · FY2005 · HL
Ubiquitination and Degradation in Cancer Therapy$173,813
R21 · FY2005 · CA
Ubiquitination and Degradation in Cancer Therapy$47,648
R21 · FY2005 · CA
The Role Of CREB In Leukemogenesis$40,040
R01 · FY2005 · HL
The Role Of CREB In Leukemogenesis$12,556
R01 · FY2005 · HL
The Role Of CREB In Leukemogenesis$303,589
R01 · FY2004 · HL
Ubiquitination and Degradation in Cancer Therapy$207,225
R21 · FY2004 · CA
MOLECULAR REGULATION OF MYELIOD CELL DIFFERENTIATION$104,300
R29 · FY2000 · CA
MOLECULAR REGULATION OF MYELIOD CELL DIFFERENTIATION$39,812
R29 · FY2000 · CA